» Articles » PMID: 21602069

Structural Determinants of the Alpha2 Adrenoceptor Subtype Selectivity

Overview
Date 2011 May 24
PMID 21602069
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Alpha2-adrenergic receptor (α2-AR) subtypes, acting mainly on the central nervous and cardiovascular systems, represent important targets for drug design, confirmed by the high number of studies published so far. Presently, only a few α2-AR subtype selective compounds are known. Using homology modeling and ligand docking, the present study analyzes the similarities and differences between binding sites, and between extracellular loops of the three subtypes of α2-ARs. Several α2-AR subtype selective ligands were docked into the active sites of the three α2-AR subtypes, key interactions between ligands and receptors were mapped, and the predicted results were compared with the available experimental data. Binding site analysis reveals a strong identity between important amino acid residues in each receptor, the very few differences being the key toward modulating selectivity of α2-AR ligands. The observed differences between binding site residues provide an excellent starting point for virtual screening of chemical databases, in order to identify potentially selective ligands for α2-ARs.

Citing Articles

The Discovery of Novel α Adrenergic Receptor Agonists Only Coupling to Gαi/O Proteins by Virtual Screening.

Zhou P, Lu F, Zhu H, Shi B, Wang X, Sun S Int J Mol Sci. 2024; 25(13).

PMID: 39000340 PMC: 11241340. DOI: 10.3390/ijms25137233.


Distinct activation mechanisms regulate subtype selectivity of Cannabinoid receptors.

Dutta S, Shukla D Commun Biol. 2023; 6(1):485.

PMID: 37147497 PMC: 10163236. DOI: 10.1038/s42003-023-04868-1.


Synthesis and biological evaluation of N-arylpiperazine derivatives of 4,4-dimethylisoquinoline-1,3(2H,4H)-dione as potential antiplatelet agents.

Marcinkowska M, Kotanska M, Zagorska A, Sniecikowska J, Kubacka M, Siwek A J Enzyme Inhib Med Chem. 2018; 33(1):536-545.

PMID: 29482394 PMC: 6010133. DOI: 10.1080/14756366.2018.1437155.


The C-terminal half of the α2C-adrenoceptor determines the receptor's membrane expression level and drug selectivity.

Jahnsen J, Uhlen S Naunyn Schmiedebergs Arch Pharmacol. 2013; 386(12):1031-40.

PMID: 23868076 DOI: 10.1007/s00210-013-0902-z.

References
1.
Young P, Berge J, Chapman H, Cawthorne M . Novel alpha 2-adrenoceptor antagonists show selectivity for alpha 2A- and alpha 2B-adrenoceptor subtypes. Eur J Pharmacol. 1989; 168(3):381-6. DOI: 10.1016/0014-2999(89)90801-7. View

2.
Jaakola V, Griffith M, Hanson M, Cherezov V, Chien E, Lane J . The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist. Science. 2008; 322(5905):1211-7. PMC: 2586971. DOI: 10.1126/science.1164772. View

3.
Kiss J, Zsilla G, Mike A, Zelles T, Toth E, Lajtha A . Subtype-specificity of the presynaptic alpha 2-adrenoceptors modulating hippocampal norepinephrine release in rat. Brain Res. 1995; 674(2):238-44. DOI: 10.1016/0006-8993(94)01447-p. View

4.
Okada T, Sugihara M, Bondar A, Elstner M, Entel P, Buss V . The retinal conformation and its environment in rhodopsin in light of a new 2.2 A crystal structure. J Mol Biol. 2004; 342(2):571-83. DOI: 10.1016/j.jmb.2004.07.044. View

5.
Boutet E, Lieberherr D, Tognolli M, Schneider M, Bairoch A . UniProtKB/Swiss-Prot. Methods Mol Biol. 2008; 406:89-112. DOI: 10.1007/978-1-59745-535-0_4. View